Literature DB >> 1977218

Differences in ischemia-induced accumulation of amino acids in the cat cortex.

N Shimada1, R Graf, G Rosner, W D Heiss.   

Abstract

It is well established that excitatory amino acid neurotransmitters are extensively liberated during ischemia and that they have neurotoxic properties contributing to neuronal injury. To study changes in the liberation of excitatory and other amino acids during cerebral ischemia, we measured their extracellular concentrations and related them to blood flow levels and electrophysiologic activity (electrocorticogram and auditory evoked potentials) before and for up to 2 hours after multiple cerebral vessel occlusion in 14 anesthetized cats. Blood flow levels between 0 and 43 ml/100 g/min were reached. Concentrations of the excitatory amino acid neurotransmitters increased most (aspartate 10-fold, glutamate 30-fold, and gamma-aminobutyric acid 300-fold compared with control values) below a blood flow threshold of 20 ml/100 g/min. The total power of the electrocorticogram and the amplitude of the auditory evoked potentials were affected below the same blood flow threshold. In contrast, concentrations of the nontransmitter amino acids taurine, alanine, asparagine, serine, and glutamine increased 1.5-5-fold as blood flow decreased, while concentrations of the essential amino acids phenylalanine, valine, leucine, and isoleucine did not change during cerebral ischemia. The great increases in concentrations of the excitatory amino acid neurotransmitters below a blood flow threshold close to that for functional disturbance is in accordance with the role of these amino acids in ischemic cell damage. Their release at blood flow levels compatible with cell survival and the increase in their concentrations with severity and duration of cerebral ischemia imply that excitotoxic antagonists may have potential as therapeutic agents.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1977218     DOI: 10.1161/01.str.21.10.1445

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  8 in total

1.  The role of taurine in neuronal protection following transient global forebrain ischemia.

Authors:  S H Khan; A Banigesh; A Baziani; K G Todd; H Miyashita; M Eweida; A Shuaib
Journal:  Neurochem Res       Date:  2000-02       Impact factor: 3.996

Review 2.  Cellular mechanisms underlying acquired epilepsy: the calcium hypothesis of the induction and maintainance of epilepsy.

Authors:  Robert J Delorenzo; David A Sun; Laxmikant S Deshpande
Journal:  Pharmacol Ther       Date:  2004-12-09       Impact factor: 12.310

3.  Energy metabolism and NAD-NADH redox state in brain slices in response to glutamate exposure and ischemia.

Authors:  S S Kannurpatti; N B Joshi
Journal:  Metab Brain Dis       Date:  1999-03       Impact factor: 3.584

Review 4.  Limiting neurological damage after stroke: a review of pharmacological treatment options.

Authors:  S J Read; T Hirano; S M Davis; G A Donnan
Journal:  Drugs Aging       Date:  1999-01       Impact factor: 3.923

5.  Neurovascular coupling varies with level of global cerebral ischemia in a rat model.

Authors:  Wesley B Baker; Zhenghui Sun; Teruyuki Hiraki; Mary E Putt; Turgut Durduran; Martin Reivich; Arjun G Yodh; Joel H Greenberg
Journal:  J Cereb Blood Flow Metab       Date:  2012-10-03       Impact factor: 6.200

6.  The recovery function of paired somatosensory evoked potentials in cerebral ischemic rabbits.

Authors:  Y Wang; K Nakashima; Y Shiraishi; Y Kawai; K Takahashi
Journal:  Exp Brain Res       Date:  1995       Impact factor: 1.972

7.  Efficacy of high dose amino acid solution on spinal cord injury induced by focal Nd:YAG laser irradiation.

Authors:  A Colak; G Nurlu; B Açikgöz; O E Ozcan
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

8.  Impact of euthanasia, dissection and postmortem delay on metabolic profile in mouse retina and RPE/choroid.

Authors:  Siyan Zhu; Michelle Yam; Yekai Wang; Jonathan D Linton; Allison Grenell; James B Hurley; Jianhai Du
Journal:  Exp Eye Res       Date:  2018-06-01       Impact factor: 3.467

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.